WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for warm AIHA: drug trial targets blood cell destruction
Disease control OngoingThis study tests a drug called HMPL-523 (Sovleplenib) in people with warm antibody autoimmune hemolytic anemia, a condition where the immune system attacks red blood cells. About 111 adults will receive either the drug or a placebo to see if it improves hemoglobin levels and cont…
Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a cancer drug tame a blood disorder?
Disease control OngoingThis phase 2 trial tests the drug acalabrutinib in people with chronic lymphocytic leukemia (CLL) who also have a blood condition called autoimmune hemolytic anemia (AIHA) that has come back or not responded to treatment. The study aims to see if acalabrutinib can control the ane…
Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC